Woodward Josha, Meza Samuel, Richards Dominick, Koro Lacin, Keegan Kevin C, Joshi Krishna C, Munoz Lorenzo F, Byrne Richard W, John Sayona
Department of Neurological Surgery, Rush University Medical Center, Chicago, IL, United States.
Department of Neurology, Rush University Medical Center, Chicago, IL, United States.
Front Surg. 2022 Jun 9;9:914798. doi: 10.3389/fsurg.2022.914798. eCollection 2022.
The SARS-CoV-2 (COVID-19) pandemic continues to substantially alter previously established clinical practice patterns and has transformed patient care in American healthcare. However, studies to evaluate the impact of COVID-19 on neuroemergent patient care and associated clinical outcomes are limited. Herein, we describe the impact of COVID-19 on the Neuroemergency Transfer Program (NTP) - a novel, urban, high volume interhospital patient transfer program.
To evaluate and describe the clinical impact of the COVID-19 pandemic on the NTP.
A single-center retrospective study of prospectively collected consecutive neuroemergent patient transfer data between 2018-2021 was analyzed. Adult patients were divided based upon transfer date into a Pre-COVID (PCOV) or COVID cohort. Patient demographics, transfer characteristics and clinical data and outcomes were analyzed.
3,096 patients were included for analysis. Mean age at transfer in the PCOV and COVID cohorts were 62.4 ± 0.36 and 61.1 ± 0.6 years. A significant decrease in mean transfers per month was observed between cohorts (PCOV = 97.8 vs. COV = 68.2 transfers/month, < 0.01). Total transfer time in the PCOV cohort was 155.1 ± 3.4 min which increased to 169.3 ± 12.8 min in the COVID cohort ( = 0.13). Overall mean transfer distance was significantly longer in the PCOV cohort at 22.0 ± 0.4 miles vs. 20.3 ± 0.67 miles in the COV cohort ( = 0.03). The relative frequency of transfer diagnoses was unchanged between cohorts. A significant increase in mean inpatient length of stay was noted, 7.9 ± 0.15 days to 9.6 ± 0.33 days in the PCOV vs. COVID cohorts ( < 0.01). Ultimately, no difference in the frequency of good vs. poor clinical outcome were noted between the PCOV (79.8% and 19.4%) vs. COV (78.8% and 20.4%) cohorts.
The impact of COVID-19 on current healthcare dynamics are far reaching. Here, we show a significant decrease in interhospital patient transfers and increased length of stay between a Pre-COVID and COVID cohort. Further work to better elucidate the specific interplay of clinical contributors to account for these changes is indicated.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)大流行持续大幅改变先前既定的临床实践模式,并改变了美国医疗保健中的患者护理方式。然而,评估新冠病毒对神经急症患者护理及相关临床结局影响的研究有限。在此,我们描述新冠病毒对神经急症转运项目(NTP)的影响——这是一个新型的、位于城市的、高流量的医院间患者转运项目。
评估并描述新冠病毒大流行对神经急症转运项目的临床影响。
对2018年至2021年期间前瞻性收集的连续神经急症患者转运数据进行单中心回顾性研究分析。成年患者根据转运日期分为新冠疫情前(PCOV)组或新冠疫情组。分析患者人口统计学、转运特征、临床数据及结局。
纳入3096例患者进行分析。PCOV组和新冠疫情组转运时的平均年龄分别为62.4±0.36岁和61.1±0.6岁。两组间每月平均转运次数显著减少(PCOV组=97.8次/月,新冠疫情组=68.2次/月,P<0.01)。PCOV组的总转运时间为155.1±3.4分钟,在新冠疫情组增加至169.3±12.8分钟(P=0.13)。PCOV组的总体平均转运距离显著更长,为22.0±0.4英里,而新冠疫情组为20.3±0.67英里(P=0.03)。两组间转运诊断的相对频率未变。注意到平均住院时长显著增加,PCOV组为7.9±0.15天,新冠疫情组为9.6±0.33天(P<0.01)。最终,PCOV组(79.8%和19.4%)与新冠疫情组(78.8%和20.4%)之间在良好与不良临床结局的频率上未发现差异。
新冠病毒对当前医疗动态的影响深远。在此,我们显示医院间患者转运显著减少,且新冠疫情前组与新冠疫情组之间住院时长增加。需要进一步开展工作以更好地阐明导致这些变化的临床因素的具体相互作用。